Amicus Therapeutics
FOLD
FOLD
286 hedge funds and large institutions have $2.87B invested in Amicus Therapeutics in 2024 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 105 increasing their positions, 104 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
286
Holders Change
-3
Holders Change %
-1.04%
% of All Funds
3.81%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
40
Increased
105
Reduced
104
Closed
42
Calls
$4.77M
Puts
$4.87M
Net Calls
-$102K
Net Calls Change
+$2.44M
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$43.4M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$42.4M |
| 3 |
VPC
Vestal Point Capital
New York
|
+$31.6M |
| 4 |
BlackRock
New York
|
+$17M |
| 5 |
O
OrbiMed
New York
|
+$16.2M |
Top Sellers
| 1 |
JPMorgan Chase & Co
New York
|
-$53.7M |
| 2 |
PA
Perceptive Advisors
New York
|
-$35.9M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$27.7M |
| 4 |
Morgan Stanley
New York
|
-$19.7M |
| 5 |
SC
Stempoint Capital
New York
|
-$15.8M |
